| 000 | 01627 a2200433 4500 | ||
|---|---|---|---|
| 005 | 20250517151011.0 | ||
| 264 | 0 | _c20181126 | |
| 008 | 201811s 0 0 eng d | ||
| 022 | _a2530-0172 | ||
| 024 | 7 |
_a10.1016/j.endinu.2017.02.010 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLópez Zubizarreta, Marco | |
| 245 | 0 | 0 |
_aTobacco and diabetes: clinical relevance and approach to smoking cessation in diabetic smokers. _h[electronic resource] |
| 260 |
_bEndocrinologia, diabetes y nutricion _cApr 2017 |
||
| 300 |
_a221-231 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 |
_aCardiovascular Diseases _xepidemiology |
| 650 | 0 | 4 |
_aDNA Methylation _xdrug effects |
| 650 | 0 | 4 |
_aDiabetes Mellitus _xepidemiology |
| 650 | 0 | 4 |
_aDiabetic Angiopathies _xetiology |
| 650 | 0 | 4 | _aDrug Interactions |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aInsulin _xpharmacokinetics |
| 650 | 0 | 4 | _aMeta-Analysis as Topic |
| 650 | 0 | 4 |
_aNeurotransmitter Agents _xmetabolism |
| 650 | 0 | 4 |
_aNicotine _xpharmacokinetics |
| 650 | 0 | 4 | _aRisk Factors |
| 650 | 0 | 4 |
_aSmoking _xepidemiology |
| 650 | 0 | 4 | _aSmoking Cessation |
| 650 | 0 | 4 |
_aTelomere Homeostasis _xdrug effects |
| 650 | 0 | 4 | _aTobacco Use Cessation Devices |
| 650 | 0 | 4 |
_aTobacco Use Disorder _xgenetics |
| 650 | 0 | 4 | _aWeight Gain |
| 700 | 1 | _aHernández Mezquita, Miguel Ángel | |
| 700 | 1 | _aMiralles García, José Manuel | |
| 700 | 1 | _aBarrueco Ferrero, Miguel | |
| 773 | 0 |
_tEndocrinologia, diabetes y nutricion _gvol. 64 _gno. 4 _gp. 221-231 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.endinu.2017.02.010 _zAvailable from publisher's website |
| 999 |
_c27089086 _d27089086 |
||